Determining Optimal Post-Stroke Exercise (DOSE)

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT01915368
Collaborator
(none)
75
8
3
75
9.4
0.1

Study Details

Study Description

Brief Summary

The investigators will conduct a proof-of-concept study to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults undergoing sub-acute stroke rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Stroke Management Program (SMP)
  • Behavioral: Stroke Monitoring Program (SMonP)
  • Behavioral: Stroke Supplementary Program (SSP)
N/A

Detailed Description

Participants admitted for stroke rehabilitation will be randomly assigned to either the Stroke Management Group, Stroke Monitoring Group or Stroke Supplementary Group. All three groups will receive usual care, in addition to the intervention. The Stroke Management Group will be provided with periodic information about their progress in the area of mobility using specialized activity monitors. The Stroke Monitoring Group will be progressed according to customized protocols using feedback from specialized activity monitors. The Stroke Supplementary Group will receive the same as the Stroke Monitoring Group, but will also receive one additional hour of daily (5 times per week) physical exercise

Study Design

Study Type:
Interventional
Actual Enrollment :
75 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Determining Optimal Post-Stroke Exercise (DOSE)
Study Start Date :
Sep 1, 2013
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Stroke Management Program (SMP)

Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors

Behavioral: Stroke Management Program (SMP)
Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors

Experimental: Stroke Monitoring Program (SMonP)

Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors

Behavioral: Stroke Monitoring Program (SMonP)
Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors

Experimental: Stroke Supplementary Program (SSP)

Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise

Behavioral: Stroke Supplementary Program (SSP)
Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise

Outcome Measures

Primary Outcome Measures

  1. Ambulatory function measured by the Six Minute Walk Test [Rehabilitation discharge (average 4-5 weeks post admission)]

Secondary Outcome Measures

  1. Ambulatory Function from the Six Minute Walk Test [6 and 12 months post-stroke]

  2. Ambulatory function from the 5 Meter Walk Test [Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke]

  3. Balance function from the Berg Balance Scale [Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke]

  4. Ambulatory function from the Functional Ambulation Classification [Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke]

  5. Quality of life measured with EuroQol [Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke]

  6. Cognition measured by the Montreal Cognitive Assessment [Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke]

  7. Cognition measured by the Digit Symbols Substitution Test [Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke]

  8. Cognition measured by the Trail Making Test [Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke]

  9. Depression measured by Patient Health Questionnaire-9 [Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke]

  10. Heart rate measured during the intervention sessions [From 10 intervention sessions within the 4-week intervention]

  11. Step count measured during the intervention sessions [From 10 intervention sessions within the 4-week intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have been admitted to a hospital unit for stroke rehabilitation

  • Within 10 weeks post-stroke

  • 19 years or older

  • Are experiencing difficulty walking

Exclusion Criteria:
  • Requires greater than one person assist for transfer or ambulation

  • Have uncontrolled medical condition or another serious medication condition in addition to stroke

  • Unable to understand or follow directions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fanning Centre Calgary Alberta Canada
2 Foothills Medical Centre Calgary Alberta Canada
3 Laurel Place Surrey British Columbia Canada V3T 4H9
4 Surrey Memorial Hospital Surrey British Columbia Canada V3V 1Z2
5 GF Strong Rehab Centre Vancouver British Columbia Canada V5Z 2G9
6 Holy Family Hospital Vancouver British Columbia Canada
7 Riverview Health Centre Winnipeg Manitoba Canada R3L 2P4
8 Toronto Rehabilitation Institute Toronto Ontario Canada

Sponsors and Collaborators

  • University of British Columbia

Investigators

  • Principal Investigator: Janice Eng, PhD, The University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Janice Eng, Principal Investigator, University of British Columbia
ClinicalTrials.gov Identifier:
NCT01915368
Other Study ID Numbers:
  • H13-01933
First Posted:
Aug 2, 2013
Last Update Posted:
Dec 16, 2019
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Janice Eng, Principal Investigator, University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 16, 2019